Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07841925 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors

Name: A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors — clinical trial record (NCT07841925)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1/2

SponsorSichuan Baili Pharmaceutical Co., Ltd.

Started2026-09

View on ClinicalTrials.gov ↗

Sichuan Baili Pharmaceutical Co., Ltd.

135 trials monitored

See 14 trials at risk

Melanoma

1,020 trials monitored

See 45 trials at risk

This Phase Ib/II study is a clinical study to explore the efficacy and safety of BL-M08D1 for injection in patients with locally advanced or metastatic melanoma and other solid tumors.

Trial Details

NCT Number	NCT07841925
Lead Sponsor	Sichuan Baili Pharmaceutical Co., Ltd. Collaborators: Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.
Conditions	Melanoma, Solid Tumors
Enrollment	30 participants
Start Date	2026-09
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-25